ROSTER

NATIONAL HEART, LUNG, AND BLOOD INSTITUTE SPECIAL EMPHASIS PANEL
CLINICAL TRIALS IN DIABETES AND CVD
SEPTEMBER 19, 1997
NIH CAMPUS, BETHESDA, MD

Agenda:  To consider the need for a clinical trial to determine
optimal intervention strategies to prevent or reduce CVD in
diabetic patients. 

CHAIRPERSON
Robert L. Frye, M.D.
Professor and Chair
Department of Medicine
Mayo Medical School
Mayo Foundation
Rochester, MN  55905

Luther Clark, M.D.
Professor of Medicine
Chief, Division of Cardiovascular Medicine
SUNY Hospital at Brooklyn
Brooklyn, NY  11203

Curt Furberg, M.D., Ph.D.
Professor and Chairman
Department of Preventive Health Sciences
Bowman Gray School of Medicine
Winston-Salem, NC  27103

Steven Haffner, M.D., MPH
Professor
Division of Clinical Epidemiology
Department of Medicine
University of Texas Health Science Center
San Antonio, TX  78284-7873

Barbara V. Howard, Ph.D.
President
Medlantic Research Institute
George Hyman Research Building
Washington, DC  20010

Gennell Knatterud, Ph.D.
President and Vice Chairman Board of Directors
Professor, Department of Epidemiology
Maryland Medical Research Institute
University of Maryland
Baltimore, MD  21201

Lewis H. Kuller, M.D., D.Ph.
Professor and Chair
Department of Epidemiology
University of Pittsburgh
Pittsburgh, PA  15261

Burton Sobel, M.D.
Professor and Chair
Department of Medicine
University of Vermont
Fletcher Allen Health Care
Burlington, VT  05405

OBSERVER
Willa Hseuh, M.D.
Professor
Department of Medicine
Chief, Division of Endocrinology, Diabetes
  and Hypertension
University of Southern California Medical Center
Los Angeles, CA  90024

PROGRAM REPRESENTATIVES
Peter Savage, M.D.
Division of Epidemiology and
  Clinical Applications, NHLBI
II Rockledge Center
Bethesda, MD  20892-7938

George Sopko, M.D.
Medical Officer, DHVD
II Rockledge Center
Bethesda, MD  20892-7940

This roster may not reflect last minute changes in the Special
Emphasis Panel composition.
.